Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Clemons

Showing results (51-60 of 267) with videos related to

Pageof 27
Sort By:
Breast (Edinburgh, Scotland)|July 10, 2010
Defining ovarian failure in amenorrheic young breast cancer patientsEitan Amir, Orit Freedman, Lisa Allen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 9, 2009
Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial settingMateya Trinkaus, Christine Simmons, Jeff Myers, et al.
Expert Opinion on Pharmacotherapy|March 29, 2014
Pharmacotherapy of bone metastases in breast cancer patients--an updateCarmel Jacobs, Demetrios Simos, Christina Addison, et al.
Expert Opinion on Pharmacotherapy|April 2, 2008
Pharmacotherapy of bone metastases in breast cancer patientsBianca Petrut, Christine Simmons, Reuben Broom, et al.
Breast Cancer Research and Treatment|May 3, 2007
A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapyMark Clemons, George Dranitsaris, Wei Ooi, et al.
Nature Reviews. Clinical Oncology|February 2, 2010
Chemotherapy: dose-dense treatment for triple-negative breast cancerEitan Amir, Alberto Ocana, Orit Freedman, et al.
Canadian Family Physician Medecin De Famille Canadien|January 22, 2009
Approach to inflammatory breast cancerAndrea Molckovsky, Barbara Fitzgerald, Orit Freedman, et al.
The Breast Journal|January 20, 2016
Issues Affecting the Loco-regional and Systemic Management of Patients with Invasive Lobular Carcinoma of the BreastCarmel Jacobs, Mark Clemons, Christina Addison, et al.
Journal of Bone Oncology|February 25, 2016
Bone-targeted therapy for metastatic breast cancer-Where do we go from here? A commentary from the BONUS 8 meetingXiaofu Zhu, Eitan Amir, Gurmit Singh, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) ProgramBader Alshamsan, Brian Hutton, Michelle Liu, et al.
Pageof 27

Showing results (51-60 of 267) with videos related to

Sort By:
Pageof 27
Breast (Edinburgh, Scotland)|July 10, 2010
Defining ovarian failure in amenorrheic young breast cancer patientsEitan Amir, Orit Freedman, Lisa Allen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 9, 2009
Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial settingMateya Trinkaus, Christine Simmons, Jeff Myers, et al.
Expert Opinion on Pharmacotherapy|March 29, 2014
Pharmacotherapy of bone metastases in breast cancer patients--an updateCarmel Jacobs, Demetrios Simos, Christina Addison, et al.
Expert Opinion on Pharmacotherapy|April 2, 2008
Pharmacotherapy of bone metastases in breast cancer patientsBianca Petrut, Christine Simmons, Reuben Broom, et al.
Breast Cancer Research and Treatment|May 3, 2007
A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapyMark Clemons, George Dranitsaris, Wei Ooi, et al.
Nature Reviews. Clinical Oncology|February 2, 2010
Chemotherapy: dose-dense treatment for triple-negative breast cancerEitan Amir, Alberto Ocana, Orit Freedman, et al.
Canadian Family Physician Medecin De Famille Canadien|January 22, 2009
Approach to inflammatory breast cancerAndrea Molckovsky, Barbara Fitzgerald, Orit Freedman, et al.
The Breast Journal|January 20, 2016
Issues Affecting the Loco-regional and Systemic Management of Patients with Invasive Lobular Carcinoma of the BreastCarmel Jacobs, Mark Clemons, Christina Addison, et al.
Journal of Bone Oncology|February 25, 2016
Bone-targeted therapy for metastatic breast cancer-Where do we go from here? A commentary from the BONUS 8 meetingXiaofu Zhu, Eitan Amir, Gurmit Singh, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) ProgramBader Alshamsan, Brian Hutton, Michelle Liu, et al.
Pageof 27